Figures in the Special Focus Profiles
ShareCompartir
STDs in Women and Infants
Figure A. Pelvic Inflammatory Disease — Initial Visits to Physicians’ Offices Among Women Aged 15–44 Years, United States, 2006–2015
Figure B. Pelvic Inflammatory Disease — Lifetime Prevalence Among Sexually Experienced Women Aged 18–44 Years by Race/Ethnicity and Previous STI Diagnosis, National Health and Nutrition Examination Survey (NHANES), 2013–2014
Figure C. Ectopic Pregnancy — Rates Among Commercially Insured Women with Live Births Aged 15–44 Years by Age Group, 2004–2015
Figure D. Chlamydia — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2016
Figure E. Gonorrhea — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2016
Figure F. Chlamydia — Positivity Among Women Aged 14–39 Years by Race/Ethnicity and Age Group in Clinics Providing Family Planning and Reproductive Health Services, STD Surveillance Network (SSuN), 2016
Figure G. Chlamydia and Gonorrhea — Rates of Reported Cases Among Infants <1 Year of Age by Year and Specimen Source, United States, 2010–2015
Figure H. Primary and Secondary Syphilis — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2016
Figure I. Congenital Syphilis — Rates of Reported Cases Among Infants by Year of Birth and State, United States and Outlying Areas, 2016
STDs in Adolescents and Young Adults
Figure J. Chlamydia — Rates of Reported Cases Among Women Aged 15–24 Years by State, United States and Outlying Areas, 2016
Figure K. Chlamydia — Rates of Reported Cases Among Men Aged 15–24 Years by State, United States and Outlying Areas, 2016
Figure L. Gonorrhea — Rates of Reported Cases Among Women Aged 15–24 Years by State, United States and Outlying Areas, 2016
Figure M. Gonorrhea — Rates of Reported Cases Among Men Aged 15–24 Years by State, United States and Outlying Areas, 2016
Figure N. Chlamydia — Prevalence Among Women Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2016
Figure O. Chlamydia — Prevalence Among Men Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2016
Figure P. Gonorrhea — Prevalence Among Women Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2016
Figure Q. Gonorrhea — Prevalence Among Men Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2016..
STDs in Racial and Ethnic Minorities
Figure R. Chlamydia — Rates of Reported Cases by Race/Ethnicity and Sex, United States, 2016
Figure S. Gonorrhea — Rate Ratios by Race/Ethnicity, United States, 2012–2016
Figure T. Gonorrhea — Rates of Reported Cases by Race/Ethnicity and Sex, United States, 2016
Figure U. Gonorrhea — Rate Ratios by Race/Ethnicity and Region, United States, 2016
Figure V. Primary and Secondary Syphilis — Rates of Reported Cases by Race/Ethnicity and Sex, United States, 2016
Figure W. Congenital Syphilis — Rates of Reported Cases by Year of Birth and Race/Ethnicity of Mother, United States, 2007–2016.
STDs in Men who Have Sex with Men
Figure X. Primary and Secondary Syphilis — Reported Cases by Sex, Sexual Behavior, and Race/Ethnicity, United States, 2016
Figure Y. Primary and Secondary Syphilis — Estimated Rates of Reported Cases Among MSM by State, United States, 2016
Figure Z. Neisseria gonorrhoeae — Percentage of Urethral Isolates Obtained from MSM Attending STD Clinics, Gonococcal Isolate Surveillance Project (GISP), 1989–2016
Figure AA. Neisseria gonorrhoeae — Percentage of Urethral Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 μg/ml) by Reported Sex of Sex Partner, Gonococcal Isolate Surveillance Project (GISP), 2006–2016
Figure BB. Gonorrhea — Estimated Rates of Reported Gonorrhea Cases by MSM, MSW, and Women, STD Surveillance Network (SSuN), 2010–2015
Figure CC. Gonorrhea and Chlamydia — Proportion of MSM Attending STD Clinics Testing Positive for Urogenital Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2016
Figure DD. Gonorrhea and Chlamydia — Proportion of MSM Attending STD Clinics Testing Positive for Rectal Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2016
Figure EE. Gonorrhea — Proportion of MSM Attending STD Clinics Testing Positive for Oropharyngeal Gonorrhea by Jurisdiction, STD Surveillance Network (SSuN), 2016
Figure FF. Proportion of MSM Attending STD Clinics with Primary and Secondary Syphilis, Urogenital Gonorrhea, or Urogenital Chlamydia by HIV Status, STD Surveillance Network (SSuN), 2016
- Page last reviewed: September 26, 2017
- Page last updated: September 26, 2017
- Content source: